Literature DB >> 23545312

Identification of one novel mutation in the C-propeptide of COL2A1 in a Chinese family with spondyloperipheral dysplasia.

Zeng Zhang1, Shi-Chang Zhao, Jin-Wei He, Wen-Zhen Fu, Chang-Qing Zhang, Zhen-Lin Zhang.   

Abstract

Spondyloperipheral dysplasia (SPD; OMIM 271700) is an autosomal dominant connective tissue disorder characterized by vertebral body abnormalities (platyspondyly, end-plate indentations), hip dysplasia and brachydactyly type E. Here, we identified a novel truncating mutation (p.Lys1444AsnfsX27) in the C-propeptide of type II collagen in an affected Chinese individual with SPD. Our findings will provide clues to the phenotype-genotype relations and may assist not only in the clinical diagnosis of SPD but also in the interpretation of genetic information used for prenatal diagnosis and genetic counseling.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23545312     DOI: 10.1016/j.gene.2013.03.083

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  A novel mutation of COL2A1 in a large Chinese family with avascular necrosis of the femoral head.

Authors:  Zeng Zhang; Kechao Zhu; Huiyong Dai; Qi Wang; Changqing Zhang; Zhenlin Zhang
Journal:  BMC Med Genomics       Date:  2021-06-04       Impact factor: 3.063

2.  Clinical and Molecular Characterization and Discovery of Novel Genetic Mutations of Chinese Patients with COL2A1-related Dysplasia.

Authors:  Yang Xu; Li Li; Chun Wang; Hua Yue; Hao Zhang; Jiemei Gu; Weiwei Hu; Lianyong Liu; Zhenlin Zhang
Journal:  Int J Biol Sci       Date:  2020-01-16       Impact factor: 6.580

3.  Short stature, platyspondyly, hip dysplasia, and retinal detachment: an atypical type II collagenopathy caused by a novel mutation in the C-propeptide region of COL2A1: a case report.

Authors:  Apiruk Sangsin; Chalurmpon Srichomthong; Monnat Pongpanich; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  BMC Med Genet       Date:  2016-12-12       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.